Sfoglia per AUTORE
ROLLA S
Collezione AOU Città della Salute di Torino

  

Items : 10

Pregnancy Epigenetic Signature in T Helper 17 and T Regulatory Cells in Multiple Sclerosis. in Frontiers in immunology / Front Immunol. 2019 Jan 8;9:3075. doi: 10.3389/fimmu.2018.03075. eCollection 2018.
2018
AOU Città della Salute di Torino

Cordero F; Brescia Morra V; Lanzillo R; Marsili A; Puorro G; Cordioli C; Turrini MV; Todros T; Cardaropoli S; D'Antuono L; Novelli F; De Mercanti S; Inaudi I; Bardina V; Ferrero G; Maglione A; Rolla S; Iannello A; De Bortoli M; Durelli L; Visconti A; Cutrupi S; Clerico M;

Lack of CD4+ T cell percent decrease in alemtuzumab-treated multiple sclerosis patients with persistent relapses. in Journal of neuroimmunology / J Neuroimmunol. 2017 Dec 15;313:89-91. doi: 10.1016/j.jneuroim.2017.10.009. Epub 2017 Oct 17.
2017
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Clerico M; Durelli L; Novelli F; Vladic A; Annovazzi P; Cocco E; Adamec I; Habek M; Horakova D; Bardina V; Rolla S; De Mercanti SF;

Adenosine A2a receptor stimulation blocks development of nonalcoholic steatohepatitis in mice by multilevel inhibition of signals that cause immunolipotoxicity. in Translational research : the journal of laboratory and clinical medicine / Transl Res. 2017 Apr;182:75-87. doi: 10.1016/j.trsl.2016.11.009. Epub 2016 Dec 6.
2017
AOU Città della Salute di Torino

Novelli F; Valente G; Bardina V; Imarisio C; Alchera E; Rolla S; Carini R;

The balance between IL-17 and IL-22 produced by liver-infiltrating T-helper cells critically controls NASH development in mice. in Clinical science (London, England : 1979) / Clin Sci (Lond). 2016 Feb;130(3):193-203. doi: 10.1042/CS20150405. Epub 2015 Nov 11.
2016
AOU Città della Salute di Torino

Novelli F; Mombello C; Follenzi A; Valente G; Cappello P; Alchera E; Imarisio C; Bardina V; Rolla S; Carini R;

Intra-tumoral IFN-?-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer. in Clinical science (London, England : 1979) / Clin Sci (Lond). 2016 Feb;130(4):247-58. doi: 10.1042/CS20150437. Epub 2015 Nov 20.
2016
AOU Città della Salute di Torino

Novelli F; Prisco D; Bani D; Cianchi F; Coratti A; Satolli MA; Giordano D; Castiglione F; Ringressi MN; Pini A; Bencini L; Bechi P; Benagiano M; D'Elios MM; Ricci F; Rolla S; Niccolai E; Taddei A; Amedei A;

Alemtuzumab long-term immunologic effect: Treg suppressor function increases up to 24 months. in Neurology(R) neuroimmunology & neuroinflammation / Neurol Neuroimmunol Neuroinflamm. 2016 Jan 21;3(1):e194. doi: 10.1212/NXI.0000000000000194. eCollect
2016
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Clerico M; Durelli L; Novelli F; Annovazzi P; Horakova D; Adamec I; Habek M; Soldo-Butkovic S; Vladic A; Cocco E; Bardina V; Cucci A; Rolla S; De Mercanti S;

Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells. in Oncotarget / Oncotarget. 2015 May 10;6(13):11098-113. doi: 10.18632/oncotarget.3572.
2015
AOU Città della Salute di Torino

Principe M; Ceruti P; Shih NY; Chattaragada MS; Rolla S; Conti L; Bestagno M; Zentilin L; Yang SH; Migliorini P; Cappello P; Burrone O; Novelli F;

Chimeric rat/human HER2 efficiently circumvents HER2 tolerance in cancer patients. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2014 Jun 1;20(11):2910-21. doi: 10.1158/1078-0432.CCR-13-2663. Epub 2014 Mar 25.
2014
AOU Città della Salute di Torino

Occhipinti S; Sponton L; Rolla S; Caorsi C; Novarino A; Donadio M; Bustreo S; Satolli MA; Pecchioni C; Marchini C; Amici A; Cavallo F; Cappello P; Pierobon D; Novelli F; Giovarelli M;

Th22 cells are expanded in multiple sclerosis and are resistant to IFN-?. in Journal of leukocyte biology / J Leukoc Biol. 2014 Dec;96(6):1155-64. doi: 10.1189/jlb.5A0813-463RR. Epub 2014 Aug 5.
2014
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Durelli L; Novelli F; De Palma R; Gned D; Brusa D; Quaglino P; De Mercanti S; Bardina V; Rolla S; Clerico M;

Vaccination with ENO1 DNA prolongs survival of genetically engineered mice with pancreatic cancer. in Gastroenterology / Gastroenterology. 2013 May;144(5):1098-106. doi: 10.1053/j.gastro.2013.01.020. Epub 2013 Jan 16.
2013
AOU Città della Salute di Torino

Cappello P; Rolla S; Chiarle R; Principe M; Cavallo F; Perconti G; Feo S; Giovarelli M; Novelli F;